Development of a core evaluation framework of value-added medicines: report 2 on pharmaceutical policy perspectives

BACKGROUND: A core evaluation framework that captures the health care and societal benefits of value added medicines (VAMs, also often called repurposed medicines) was proposed in Report 1, aiming to reduce the heterogeneity in value assessment processes across countries and to create incentives for...

Full description

Saved in:
Bibliographic Details
Published in:Cost Eff Resour Alloc
Main Authors: Kaló, Zoltán, Petykó, Zsuzsanna Ida, Fricke, Frank-Ulrich, Maniadakis, Nikos, Tesař, Tomáš, Podrazilová, Kateřina, Espin, Jaime, Inotai, András
Format: Artigo
Language:Inglês
Published: BioMed Central 2021
Subjects:
Review
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8280561/
https://ncbi.nlm.nih.gov/pubmed/34266465
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12962-021-00296-2
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items